Aviva
ATRC icon

Aviva’s AtriCure ATRC Stock Holding History

Aviva’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,430
Closed -$1.27M – 870
2021
Q1 		$1.27M Sell
19,430
-12,838
-40% -$791K 0.01% 760
2020
Q4 		$1.8M Sell
32,268
-26,161
-45% -$1.13M 0.01% 701
2020
Q3 		$2.33M Buy
58,429
+7,100
+14% +$301K 0.01% 665
2020
Q2 		$2.31M Sell
51,329
-67,097
-57% -$2.92M 0.01% 677
2020
Q1 		$3.98M Buy
+118,426
New +$4.26M 0.03% 463

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Aviva's ATRC Position: Q2 2021 in Review

Aviva sold out of AtriCure (ATRC) in Q2 2021, closing a stake of 19,430 shares — an estimated $1.27M sold.

Aviva first reported a position in ATRC in Q1 2020 and held it in 5 quarters. The position peaked at $3.98M in Q1 2020. 212 funds tracked by Wall St. Rank hold ATRC as of Q2 2021.

  • Aviva reported no remaining AtriCure position as of Q2 2021 after selling out during the quarter.
  • Aviva sold 19,430 AtriCure shares in Q2 2021, an estimated $1.27M.
  • Aviva first reported a position in AtriCure in Q1 2020 and held it in 5 quarters.
  • Aviva's AtriCure position peaked at $3.98M in Q1 2020.
  • 212 funds tracked by Wall St. Rank held AtriCure as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.